Cargando…
Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020
BACKGROUND: Cancer patients had been profoundly affected by the outbreak of COVID-19 especially after quarantine restrictions in China. We aimed to explore the treatment changes and delays of early breast cancer (EBC) during the first quarter of 2020. METHODS: We did this retrospective, multicentre,...
Autores principales: | Li, Jianbin, Wang, Haibo, Geng, Cuizhi, Liu, Zhenzhen, Lin, Ying, Nie, Jianyun, Sun, Gang, Ouyang, Quchang, Wang, Xiaojia, Li, Xingrui, Liu, Yinhua, Chen, Qianjun, Fu, Peifen, Yao, Feng, Chen, Jishang, Chen, Yiding, Zhao, Haidong, Yin, Yongmei, Zhang, Jingjie, Chen, Jiayi, Kong, Xiangshun, Cheng, Jing, Zhang, Haiqing, Peng, Shijun, Wang, Geng, Jin, Feng, Liu, Yunjiang, Wu, Gang, Sun, Shengrong, Jiang, Zefei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511845/ https://www.ncbi.nlm.nih.gov/pubmed/32989430 http://dx.doi.org/10.1016/j.eclinm.2020.100503 |
Ejemplares similares
-
Safety and Current Status of the COVID-19 Vaccine among Patients with Breast cancer: A Cross-Sectional Study from China
por: Zhang, Shaohua, et al.
Publicado: (2023) -
Role of locoregional surgery in patients with de novo stage IV breast cancer: analysis of real-world data from China
por: Ma, Li, et al.
Publicado: (2020) -
Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
por: Zhu, Jiujun, et al.
Publicado: (2020) -
Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021
por: Li, Jianbin, et al.
Publicado: (2023) -
Exploratory clinical study of chidamide, an oral subtype-selective histone deacetylase inhibitor, in combination with exemestane in hormone receptor-positive advanced breast cancer
por: Zhang, Qingyuan, et al.
Publicado: (2018)